Results 121 to 130 of about 18,344 (221)

Activation of β2-Adrenergic Receptor Alleviates Viral Myocarditis by Regulating Energy Metabolism in Monocyte-derived Macrophages via the AMPK Pathway. [PDF]

Inflammation
Li QL, Guo YX, Li JF, Xie HB, Qian J, Wu WF.   +5 more
europepmc   +1 more source

Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in patients with tuberculosis-associated chronic obstructive pulmonary disease: study protocol for a randomised controlled trial. [PDF]

J Thorac Dis
Wu F, Huang S, Lei M, Deng Z, Wan Q, Tang G, Zhou K, Liang X, Abduwaiti T, Turgon R, Zhang K, Turgon K, Li Y, Li H, Zou W.   +14 more
europepmc   +1 more source

A Study on the Use of Nebulized Glycopyrronium in Hospitalized Patients With Exacerbations of Obstructive Airway Disease. [PDF]

Cureus
Khanna A, Tandon A, Narasimhan R L.
europepmc   +1 more source

The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma [PDF]

, 2018
Bacharier, Leonard B, Chipps, Bradley E, Farrar, Judith R, Jackson, Daniel J, Murphy, Kevin R, Phipatanakul, Wanda, Szefler, Stanley J, Teague, W. Gerald, Zeiger, Robert S   +8 more
core   +2 more sources

Letter to the Editor Regarding "Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study". [PDF]

Adv Ther
Golpe R.
europepmc   +1 more source

Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies. [PDF]

Ther Adv Respir Dis
Bednarczyk A, Aurivillius M, Jassal M, Shah M, Raphiou I, Petullo D, Xu J, Heijer M, Sychowicz K, Collison K, Silva C, Reddy J, Han D, Goldwater R, Gillen M, Patel M.   +15 more
europepmc   +1 more source

Hyperglycemia impairs microglia responding to retinal vasculopathy via enhanced norepinephrine-ADRB2 signaling. [PDF]

J Neuroinflammation
Bu S, Mou B, Xiang Z, Zhang L, Hao B, Chen J, Huang L, Ruan X, Liu YU, Zhang Y.   +9 more
europepmc   +1 more source

Response to: Letter to the Editor Regarding 'Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study'. [PDF]

Adv Ther
Alcázar-Navarrete B, Figueira-Gonçalves JM, Corregidor-García C, Fitas E, Sánchez-Covisa J.   +4 more
europepmc   +1 more source

Anti-inflammatory reliever therapy for asthma using inhaled budesonide/formoterol as-needed with or without maintenance in South African children (AIR-SA 001): a description of a randomised clinical trial protocol. [PDF]

BMJ Open Respir Res
Hlophe ST, Ndimande NN, Ngobese N, Mkwanazi E, Bird K, Mbonigaba J, Otwombe K, Lebina L, Mortimer K, Masekela R.   +9 more
europepmc   +1 more source

Budesonide/formoterol for pediatric asthma: bridging the gap between evidence and practice in Maintenance and Reliever Therapy. [PDF]

Front Med (Lausanne)
Tian FX, Wang XP, Wang DM.
europepmc   +1 more source